Ian D Davis

Ian D Davis

UNVERIFIED PROFILE

Are you Ian D Davis?   Register this Author

Register author
Ian D Davis

Ian D Davis

Publications by authors named "Ian D Davis"

Are you Ian D Davis?   Register this Author

100Publications

2584Reads

45Profile Views

Body size and dietary risk factors for aggressive prostate cancer: a case-control study.

Cancer Causes Control 2019 Dec 24;30(12):1301-1312. Epub 2019 Sep 24.

Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-019-01234-7DOI Listing
December 2019

Circulating oestrogen receptor mutations and splice variants in advanced prostate cancer.

BJU Int 2019 Nov 3;124 Suppl 1:50-56. Epub 2019 Oct 3.

Eastern Health Clinical School, Monash University, Box Hill, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.14797DOI Listing
November 2019

Enzalutamide in Metastatic Prostate Cancer. Reply.

N Engl J Med 2019 10;381(15):1494-1495

Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1910553DOI Listing
October 2019

The impact of chemotherapy on cognitive function: a multicentre prospective cohort study in testicular cancer.

Support Care Cancer 2019 Oct 23. Epub 2019 Oct 23.

Faculty of Health and Medical Sciences, University of Adelaide, Frome Road, Adelaide, South Australia, 5005, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-019-05095-3DOI Listing
October 2019

Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer.

N Engl J Med 2019 07 2;381(2):121-131. Epub 2019 Jun 2.

From Monash University (I.D.D., M.F., D.W.P.), Eastern Health (I.D.D.), Australian Urology Associates (M.F.), Monash Health (D.W.P.), and the Peter MacCallum Cancer Centre and the University of Melbourne (S.K.S., S.G.W.), Melbourne, VIC, the National Health and Medical Research Council Clinical Trials Centre, University of Sydney (A.J.M., M.R.S., X.C., W.E.H., E.T., S.Y., A.Y.Z.), the Chris O'Brien Lifehouse (M.R.S., L.G.H., A.Y.Z.), the University of Sydney (L.G.H., G.M.), Royal Prince Alfred Hospital (L.G.H.), Kinghorn Cancer Centre, St. Vincent's Hospital, and Garvan Institute of Medical Research (A.M.J.), Macquarie University (A.Y.Z.), and Western Sydney University (R.R.Z.), Sydney, Concord Cancer Centre, Concord Repatriation General Hospital, Concord, NSW (M.R.S.), Port Macquarie Base Hospital and Mid North Coast Cancer Institute Port Macquarie, Port Macquarie, NSW (S.B.), Sydney Adventist Hospital, Wahroonga, NSW (G.M.), the ANZUP Cancer Trials Group, Camperdown, NSW (M.M.), the Adelaide Cancer Centre and the University of Adelaide (F.P.) and the Royal Adelaide Hospital (T.H.T.), Adelaide, SA, and Orange Health Service, Central West Cancer Care Centre, Orange, NSW (R.R.Z.) - all in Australia; BC Cancer and the University of British Columbia, Vancouver (K.N.C.), the Cross Cancer Institute and the University of Alberta, Edmonton (S.A.N.), Canadian Cancer Trials Group, Queen's University (W.P., F.V.-B.), and the Kingston Health Sciences Center (F.V.-B.), Kingston, ON, and the University of Ottawa and the Ottawa Hospital Research Institute, Ottawa (M.N.R.) - all in Canada; Guy's and St. Thomas' NHS Foundation Trust Biomedical Research Centre, Cancer Research UK and King's College London, and Sarah Cannon Research UK, London (S.C.), and the Royal Cornwall Hospital, Truro (A. Thomson) - all in the United Kingdom; Auckland City Hospital, Auckland (N.J.L.), and the Waikato District Health Board, Hamilton (A. Tan) - both in New Zealand; Cancer Trials Ireland (J.M., R.M.), Mater Misericordiae University Hospital (J.M.), and St. Vincent's University Hospital and University College Dublin (R.M.D.) - all in Dublin; and Dana-Farber Cancer Institute and Harvard Medical School (C.J.S.) - both in Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1903835DOI Listing
July 2019

Incident Chronic Kidney Disease After Radical Nephrectomy for Renal Cell Carcinoma.

Clin Genitourin Cancer 2019 06 15;17(3):e581-e591. Epub 2019 Mar 15.

QIMR Berghofer Medical Research Institute, Brisbane, Australia; University of Queensland, Brisbane, Australia.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15587673193005
Publisher Site
http://dx.doi.org/10.1016/j.clgc.2019.02.011DOI Listing
June 2019

Identification of novel oncogenic events occurring early in prostate carcinogenesis using purified autologous malignant and non-malignant prostate epithelial cells.

BJU Int 2019 May;123 Suppl 5:27-35

Eastern Health Clinical School, Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Vic., Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bju.14695
Publisher Site
http://dx.doi.org/10.1111/bju.14695DOI Listing
May 2019

Prognostic Utility of a Whole-blood Androgen Receptor-based Gene Signature in Metastatic Castration-resistant Prostate Cancer.

Eur Urol Focus 2019 May 15. Epub 2019 May 15.

Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, VIC, Australia; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2019.04.020DOI Listing
May 2019

Tumor size and postoperative kidney function following radical nephrectomy.

Clin Epidemiol 2019 6;11:333-348. Epub 2019 May 6.

Department of Population Health, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/CLEP.S197968DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511655PMC
May 2019

Clinical Trials of Metastatic Castration-sensitive Prostate Cancer: Recent Progress and New Horizons.

Eur Urol Focus 2019 03 14;5(2):165-167. Epub 2018 Dec 14.

Monash University, Melbourne, Australia; Eastern Health, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2018.12.001DOI Listing
March 2019

Exploring the spectrum of late effects following radical orchidectomy for stage I testicular seminoma: a systematic review of the literature.

Support Care Cancer 2019 Feb 22;27(2):373-382. Epub 2018 Oct 22.

Eastern Health Cancer Services, Level 4, 8 Arnold St., Box Hill, VIC, 3128, Australia.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00520-018-4492-7
Publisher Site
http://dx.doi.org/10.1007/s00520-018-4492-7DOI Listing
February 2019

Good clinical practice can and must include comparative effectiveness research.

BJU Int 2018 11 13;122 Suppl 5:7-8. Epub 2018 Nov 13.

University of Otago, Christchurch, New Zealand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.14590DOI Listing
November 2018

Interpolation to define clinical tumor stage in prostate cancer using clinical description of digital rectal examination.

Asia Pac J Clin Oncol 2018 Oct 27;14(5):e412-e419. Epub 2018 Apr 27.

Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12875DOI Listing
October 2018

Answering Questions and Questioning Answers: More Evidence To Guide Decision-making About Chemohormonal Therapy in Metastatic Prostate Cancer.

Authors:
Ian D Davis

Eur Urol 2018 06 7;73(6):856-858. Epub 2018 Mar 7.

Department of Medicine, Monash University and Eastern Health, Melbourne, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2018.02.020DOI Listing
June 2018

Early-onset baldness and the risk of aggressive prostate cancer: findings from a case-control study.

Cancer Causes Control 2018 01 14;29(1):93-102. Epub 2017 Nov 14.

Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-017-0981-0DOI Listing
January 2018

Posterior reversible encephalopathy syndrome mimicking brain metastases in a patient with metastatic transitional cell carcinoma.

Asia Pac J Clin Oncol 2017 Oct 11;13(5):e534-e536. Epub 2016 Oct 11.

Eastern Health Clinical School, Monash University, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12510DOI Listing
October 2017

Ejaculatory frequency and the risk of aggressive prostate cancer: Findings from a case-control study.

Urol Oncol 2017 08 27;35(8):530.e7-530.e13. Epub 2017 Mar 27.

Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2017.03.007DOI Listing
August 2017

BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned.

BJU Int 2017 05;119 Suppl 5:55-57

Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Camperdown, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.13873DOI Listing
May 2017

Challenges of data sharing: valuable but costly?

Authors:
Ian D Davis

Lancet Oncol 2017 01 16;18(1):15-16. Epub 2016 Nov 16.

Monash University, and Eastern Health, Box Hill, Vic 3128, Australia. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14702045163056
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(16)30564-2DOI Listing
January 2017

Mindfulness-Based Cognitive Therapy in Advanced Prostate Cancer: A Randomized Controlled Trial.

J Clin Oncol 2017 Jan 21;35(3):291-297. Epub 2016 Nov 21.

Suzanne K. Chambers, Stefano Occhipinti, Melissa Legg, and David P. Smith, Griffith University, Gold Coast; Suzanne K. Chambers, Samantha Clutton, Melissa Legg, Cancer Council Queensland; Robert A. Gardiner, University of Queensland, Brisbane; Suzanne K. Chambers, University of Southern Queensland, Toowoomba, Queensland; Suzanne K. Chambers, Prostate Cancer Foundation of Australia; Suzanne K. Chambers, Stefano Occhipinti, Samantha Clutton, Melissa Legg, Martin Berry, Martin R. Stockler, Mark Frydenberg, Robert A. Gardiner, Ian D. Davis, and David P. Smith, Australian and New Zealand Urogenital and Prostate Cancer Trials Group; Elizabeth Foley, Mind Potential; Martin R. Stockler, and David P. Smith, University of Sydney; David P. Smith, Cancer Council New South Wales, Sydney; Martin Berry, Central Coast Cancer Centre, Gosford; Martin R. Stockler, Concord Repatriation General Hospital, Concord, New South Wales; Suzanne K. Chambers, Robert A. Gardiner, Edith Cowan University, Perth, Western Australia; Mark Frydenberg, Monash Health; Mark Frydenberg, Ian D. Davis, Monash University; Ian D. Davis, Eastern Health, Melbourne, Victoria, Australia; and Stephen J. Lepore, Temple University, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://clf1.medpagetoday.com/content/pdf/reading-room/asco/J
Web Search
http://dx.doi.org/10.1200/JCO.2016.68.8788DOI Listing
January 2017

Lymphadenectomy with radical cystectomy at an Australian tertiary referral institution: time trends and impact on oncological outcomes.

ANZ J Surg 2015 Jul-Aug;85(7-8):535-9. Epub 2014 Jul 14.

Department of Urology, Austin Health, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ans.12772DOI Listing
October 2016

Fully automated synthesis of [(18) F]fluoro-dihydrotestosterone ([(18) F]FDHT) using the FlexLab module.

J Labelled Comp Radiopharm 2016 08 4;59(10):424-8. Epub 2016 Jul 4.

Department of Molecular Imaging and Therapy, Austin Health, Heidelberg, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jlcr.3417DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990449PMC
August 2016

In vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PET.

Asia Ocean J Nucl Med Biol 2014 ;2(1):3-11

Centre for PET, Austin Hospital, Heidelberg, Victoria, Australia; Ludwig Institute for Cancer Research, Austin Hospital, Heidelberg, Victoria, Australia; Department of Medicine, University of Melbourne, Austin Hospital, Heidelberg, Victoria, Australia.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937709PMC
July 2016

Health-Related Quality of Life, Psychological Distress, and Sexual Changes Following Prostate Cancer: A Comparison of Gay and Bisexual Men with Heterosexual Men.

J Sex Med 2016 Mar 4;13(3):425-34. Epub 2016 Feb 4.

Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jsxm.2015.12.026DOI Listing
March 2016

Mycoplasma Infection Alters Cancer Stem Cell Properties in Vitro.

Stem Cell Rev Rep 2016 Feb;12(1):156-61

Ludwig Institute for Cancer Research, Austin Hospital, Studley Road, Heidelberg, VIC, 3084, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12015-015-9630-8DOI Listing
February 2016

Patterns of care for metastatic renal cell carcinoma in Australia.

BJU Int 2015 Oct 21;116 Suppl 3:36-41. Epub 2015 Jul 21.

Department of Medical Oncology, The Royal Melbourne Hospital, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bju.13176
Publisher Site
http://dx.doi.org/10.1111/bju.13176DOI Listing
October 2015

Early recognition of ipilimumab-related autoimmune hypophysitis in patients with metastatic melanoma: Case studies and recommendations for management.

Asia Pac J Clin Oncol 2015 Jun 9;11(2):190-4. Epub 2015 Apr 9.

Department of Medical Oncology, Eastern Health, Box Hill, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12348DOI Listing
June 2015

Comparison of [(11)C]choline Positron Emission Tomography With T2- and Diffusion-Weighted Magnetic Resonance Imaging for Delineating Malignant Intraprostatic Lesions.

Int J Radiat Oncol Biol Phys 2015 Jun 8;92(2):438-45. Epub 2015 Apr 8.

Radiation Oncology Centre, Austin Health, Victoria, Australia; University of Melbourne, Victoria, Australia; Royal Marsden Hospital, National Health Service Foundation Trust, London, United Kingdom; Department of Medical Imaging and Radiation Sciences, Monash University, Victoria, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2015.02.004DOI Listing
June 2015

Low-dose cyclophosphamide enhances antigen-specific CD4(+) T cell responses to NY-ESO-1/ISCOMATRIX™ vaccine in patients with advanced melanoma.

Cancer Immunol Immunother 2015 Apr 7;64(4):507-18. Epub 2015 Feb 7.

Ludwig Institute for Cancer Research (Melbourne-Austin Branch), 147-163 Studley Road, Heidelberg, VIC, 3084, Australia,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-015-1656-xDOI Listing
April 2015

An open-label extension study to evaluate safety and efficacy of pazopanib in patients with advanced renal cell carcinoma.

Oncology 2014 6;87(6):342-50. Epub 2014 Sep 6.

Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000366227DOI Listing
January 2015

Advanced renal cell carcinoma in Australia, 2015: what should we do?

Authors:
Ian D Davis

Asia Pac J Clin Oncol 2014 Dec;10(4):285-8

Eastern Health Clinical School, Monash University and Eastern Health, Box Hill, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12314DOI Listing
December 2014

Uro-oncology multidisciplinary meetings at an Australian tertiary referral centre--impact on clinical decision-making and implications for patient inclusion.

BJU Int 2014 Nov 29;114 Suppl 1:50-4. Epub 2014 Jul 29.

Department of Urology, Austin Health, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12764DOI Listing
November 2014

Multidisciplinary consensus: a practical guide for the integration of abiraterone into clinical practice.

Asia Pac J Clin Oncol 2014 Sep 17;10(3):228-36. Epub 2014 Aug 17.

Sydney Adventist Hospital, University of Sydney, Wahroonga, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12264DOI Listing
September 2014

A single-centre experience of patients with metastatic melanoma enrolled in a dabrafenib named patient programme.

Melanoma Res 2014 Apr;24(2):144-9

aLudwig Institute for Cancer Research - Austin Branch, Joint Ludwig-Austin Medical Oncology Unit, Olivia Newton John Cancer and Wellness Centre, Austin Health bEastern Health Clinical School, Monash University, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000036DOI Listing
April 2014

Extracranial oligometastatic renal cell carcinoma: current management and future directions.

Future Oncol 2014 Apr;10(5):761-74

Department of Radiation Oncology, Calvary Mater Hospital, Edith Street, Waratah NSW 2298, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.14.40DOI Listing
April 2014

Efficacy of sorafenib in advanced renal cell carcinoma independent of prior treatment, histology or prognostic group.

Asia Pac J Clin Oncol 2014 Mar 24;10(1):60-5. Epub 2013 Oct 24.

Joint Austin-Ludwig Oncology Unit, Austin Health, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12122DOI Listing
March 2014

Contemporary management of renal cell carcinoma (RCC) in Victoria: implications for longer term outcomes and costs.

BJU Int 2013 Nov;112 Suppl 2:36-43

Department of Surgery, The Austin and Repatriation Medical Centre, Heidelberg; Department of Urology, The Austin and Repatriation Medical Centre, Heidelberg.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12204DOI Listing
November 2013

USANZ: Time-trends in use and impact on outcomes of perioperative chemotherapy in patients treated with radical cystectomy for urothelial bladder cancer.

BJU Int 2013 Nov;112 Suppl 2:74-82

Joint Austin-Ludwig Oncology Unit, Austin Health; Ludwig Institute for Cancer Research, Austin Health; University of Melbourne.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12384DOI Listing
November 2013

IL-21 Modulates Activation of NKT Cells in Patients with Stage IV Malignant Melanoma.

Clin Transl Immunology 2013 Oct 18;2(10):e6. Epub 2013 Oct 18.

Department of Microbiology and Immunology, University of Melbourne , Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/cti.2013.7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232058PMC
October 2013

Intratumoral genetic heterogeneity in metastatic melanoma is accompanied by variation in malignant behaviors.

BMC Med Genomics 2013 Oct 11;6:40. Epub 2013 Oct 11.

Cancer Immuno-biology Lab, Ludwig Institute for Cancer Research Melbourne, Austin Branch, Melbourne, Victoria 3084, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1755-8794-6-40DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852494PMC
October 2013

Cell mates: paracrine and stromal targets for prostate cancer therapy.

Nat Rev Urol 2013 Aug 16;10(8):441-51. Epub 2013 Jul 16.

Monash University Eastern Health Clinical School, Level 2, 5 Arnold Street, Box Hill, Melbourne, VIC 3128, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrurol.2013.146DOI Listing
August 2013

The Ludwig institute for cancer research Melbourne melanoma cell line panel.

Pigment Cell Melanoma Res 2013 Jul 11;26(4):597-600. Epub 2013 Apr 11.

Ludwig Institute for Cancer Research, Austin Hospital Level 5, Olivia Newton-John Cancer & Wellness Centre, Heidelberg, Vic., Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12097DOI Listing
July 2013

Patterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancer.

BJU Int 2013 Jul;112(2):E35-43

Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group Ltd, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12221DOI Listing
July 2013

Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011.

Med J Aust 2013 Jun;198(10):540-5

Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5694/mja12.11241DOI Listing
June 2013

Intravesical chemotherapy plus bacille Calmette-Guérin in non-muscle invasive bladder cancer: a systematic review with meta-analysis.

BJU Int 2013 May 17;111(6):977-83. Epub 2012 Dec 17.

National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2012.11390.xDOI Listing
May 2013

The Prostate Cancer Registry: monitoring patterns and quality of care for men diagnosed with prostate cancer.

BJU Int 2013 Apr 1;111(4 Pt B):E158-66. Epub 2012 Nov 1.

Centre of Research Excellence in Patient Safety, Monash University, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2012.11530.xDOI Listing
April 2013

Human perforin mutations and susceptibility to multiple primary cancers.

Oncoimmunology 2013 Apr;2(4):e24185

Cancer Immunology Program; Peter MacCallum Cancer Institute; East Melbourne, VIC Australia; and Sir Peter MacCallum Department of Oncology; The University of Melbourne; Melbourne, VIC Australia ; Research Division; Peter MacCallum Cancer Centre; East Melbourne, VIC Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.24185DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654607PMC
April 2013

Clinical effectiveness research: a critical need for health sector research governance capacity.

Med J Aust 2013 Mar;198(4):191-2

Eastern Health Clinical School, Monash University and Eastern Health, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5694/mja12.11144DOI Listing
March 2013

Flt3 ligand expands CD4+ FoxP3+ regulatory T cells in human subjects.

Eur J Immunol 2013 Feb 5;43(2):533-9. Epub 2012 Dec 5.

Ludwig Institute for Cancer Research, Melbourne Centre for Clinical Sciences, Heidelberg, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.201242603DOI Listing
February 2013

Oncology health information quality on the Internet: a multilingual evaluation.

Ann Surg Oncol 2012 Mar 7;19(3):706-13. Epub 2011 Dec 7.

Ludwig Institute for Cancer Research, Austin Hospital, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-011-2137-xDOI Listing
March 2012

A novel method for detecting antigen-specific human regulatory T cells.

J Immunol Methods 2012 Mar 13;377(1-2):56-61. Epub 2012 Jan 13.

Ludwig Institute for Cancer Research (Melbourne-Austin Branch), Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2012.01.004DOI Listing
March 2012

Stem cell media culture of melanoma results in the induction of a nonrepresentative neural expression profile.

Stem Cells 2012 Feb;30(2):336-43

Cancer Immuno-biology Lab, Ludwig Institute for Cancer Research, Melbourne-Austin Branch, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/stem.786
Publisher Site
http://dx.doi.org/10.1002/stem.786DOI Listing
February 2012

Urothelial cancers: using biology to improve outcomes.

Expert Rev Anticancer Ther 2012 Jan;12(1):87-98

Joint Ludwig Austin Oncology Unit, Austin Hospital LTB6, Heidelberg, VIC 3084, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.11.195DOI Listing
January 2012

The Ets transcription factor ELF5 functions as a tumor suppressor in the kidney.

Twin Res Hum Genet 2011 Aug;14(4):316-22

Centre for Functional Genomics and Human Disease, Monash Institute of Medical Research, Monash University, Australia.

View Article

Download full-text PDF

Source
http://www.journals.cambridge.org/abstract_S1832427400011518
Publisher Site
http://dx.doi.org/10.1375/twin.14.4.316DOI Listing
August 2011

Melanoma vaccines: developments over the past 10 years.

Expert Rev Vaccines 2011 Jun;10(6):853-73

Ludwig Institute for Cancer Research, Austin Branch, Austin Hospital, Studley Road, Heidelberg, Victoria, 3084, Australia.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/erv.11.74
Publisher Site
http://dx.doi.org/10.1586/erv.11.74DOI Listing
June 2011

Prostate cancer immunology - an update for Urologists.

BJU Int 2011 Apr 10;107(7):1046-51. Epub 2010 Nov 10.

Department of Surgery, University of Melbourne, Austin Hospital, Urology Unit, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2010.09820.xDOI Listing
April 2011

Potential of imaging biomarkers for characterization of renal masses.

Expert Rev Anticancer Ther 2010 Jun;10(6):781-6

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.10.69DOI Listing
June 2010

Functional imaging of renal cell carcinoma.

Nat Rev Urol 2010 May;7(5):258-66

Department of Surgical Oncology, University of Toronto, Princess Margaret Hospital, ON, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007%2F978-3-642-405
Web Search
http://www.nature.com/doifinder/10.1038/nrurol.2010.40
Publisher Site
http://dx.doi.org/10.1038/nrurol.2010.40DOI Listing
May 2010